Completed PHASE3 INTERVENTIONAL 1-arm NCT01064960

Therapeutic MRI-HIFU Ablation of Uterine Fibroids in a 3T MRI Scanner

Clinical Trial Protocol for Therapeutic MRI-guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids in a 3T MRI Scanner

Sponsor: Philips Healthcare

Conditions Uterine Leiomyomas

Interventions Philips MR-guided HIFU system

Updated 5 times since 2017 Last updated: Dec 3, 2012 Started: Jan 31, 2010 Primary completion: Jul 31, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01064960, this PHASE3 trial focuses on Uterine Leiomyomas and remains completed. Sponsored by Philips Healthcare, it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Philips Healthcare
Philips Medical Systems

Data source: Philips Healthcare

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway